Skip to content

+1 410-501-5777

info@fdamap.com

Icon-instagram-1 Threads Icon-facebook Icon-linkedin
  • Home
  • About
    • About FDA Map
    • Leadership
    • Testimonials
  • Training
    • Webinars
    • Workshops
    • Custom Training
  • Services
    • Clinical Trial
    • Regulatory Services
    • Project Management
    • FDA Auditing
    • IND Submission
    • 510(k) Submission
    • Quality Assurance
    • Site Certification
  • Insights
    • Blog
    • Articles
    • Press Releases
    • Resources
  • Contact Us
Contact Us
  • Home
  • About
    • About FDA Map
    • Leadership
    • Testimonials
  • Training
    • Webinars
    • Workshops
    • Custom Training
  • Services
    • Clinical Trial
    • Regulatory Services
    • Project Management
    • FDA Auditing
    • IND Submission
    • 510(k) Submission
    • Quality Assurance
    • Site Certification
  • Insights
    • Blog
    • Articles
    • Press Releases
    • Resources
  • Contact Us

Day: February 20, 2025

Should You Delay Your Submissions if Your FDA Review Team Got Fired?

April 4, 2025February 20, 2025 by iwewlkws

What if the people involved in the review of your application at the FDA got fired? It is not an anecdote but the reality that hit several companies last week. What is expected from the sponsors working with those individuals who are no longer employed by the FDA? It’s a tough question. There are some … Read more

Categories Blog Leave a comment

Will FDA’s Political Vulnerability Influence What New Drugs Are Approved?

April 4, 2025February 20, 2025 by iwewlkws

The kind of cuts in its workforce and major policy changes that the FDA has seen in the last month, it did not see in its entire 100-plus-year history. This, in turn, has exposed what the FDA was always accused of; being a strongly politically-influenced organization that is not as independent as it claims. But … Read more

Categories Blog Leave a comment

Recent Posts

  • FDA to Use ChatGPT-Like LLMs for Application Reviews 
  • HHS and FDA Launch Bold Drive to Cut Regulations 
  • FDA to Increase Unannounced Foreign GMP Inspections 
  • Manufacturing Drugs in the US: The Real Challenge
  • Clinical Trials Meet Real-World Data

Recent Comments

No comments to show.

One-stop source for FDA consultation, regulatory affairs training, and clinical trial services.

Icon-instagram-1 Threads Icon-facebook Icon-linkedin

Services

  • Webinars
  • Workshops
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions

Company

  • About Us
  • Our Client
  • Testimonials
  • Free Resources
  • Newsletter

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy

Copyright © 2025 FDAMap.com. All rights reserved.